| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/14656566.2016.1261110 |
| P698 | PubMed publication ID | 27841020 |
| P2093 | author name string | Yasushi Tanaka | |
| Hiroyuki Kato | |||
| Akio Ohta | |||
| Yoshio Nagai | |||
| Yukiyoshi Sada | |||
| P2860 | cites work | Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications | Q34120717 |
| Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus | Q34617065 | ||
| Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan | Q35049845 | ||
| Dapagliflozin lowers plasma glucose concentration and improves β-cell function | Q35578244 | ||
| Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction | Q35957448 | ||
| Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion | Q35981591 | ||
| SGLT2 inhibitors - an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin | Q36277977 | ||
| Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients | Q37524302 | ||
| Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. | Q40452210 | ||
| Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. | Q41015653 | ||
| Effect of insulin glargine on endogenous insulin secretion and beta-cell function in Japanese type 2 diabetic patients using oral antidiabetic drugs | Q42445421 | ||
| Effect of sitagliptin on glycemic control and beta cell function in Japanese patients given basal-supported oral therapy for type 2 diabetes | Q42465820 | ||
| Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin | Q44653784 | ||
| Proinsulin-to-C-peptide ratio versus proinsulin-to-insulin ratio in the prediction of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS). | Q46114555 | ||
| Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. | Q46576386 | ||
| Ameliorated pancreatic β cell dysfunction in type 2 diabetic patients treated with a sodium-glucose cotransporter 2 inhibitor ipragliflozin | Q51022740 | ||
| Hyperproinsulinemia is not a characteristic feature in the offspring of patients with different phenotypes of type II diabetes. | Q51554771 | ||
| Decreased hepatic insulin extraction in subjects with mild glucose intolerance. | Q51647141 | ||
| Induction of Long-Term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients by Transient Intensive Insulin Treatment | Q57499758 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type 2 diabetes | Q3025883 |
| P304 | page(s) | 13-17 | |
| P577 | publication date | 2016-11-12 | |
| P1433 | published in | Expert Opinion on Pharmacotherapy | Q5421212 |
| P1476 | title | Effect of 24-week treatment with ipragliflozin on proinsulin/C-peptide ratio in Japanese patients with type 2 diabetes. | |
| P478 | volume | 18 |
| Q64080624 | Differing Effect of the Sodium-Glucose Cotransporter 2 Inhibitor Ipragliflozin on the Decrease of Fat Mass vs. Lean Mass in Patients With or Without Metformin Therapy | cites work | P2860 |
Search more.